October 18, 2023 In-Person Health, Biotech & Pharma CLE Institute

Join ACCGP for an in-person Health, Biotech & Pharma CLE Institute at Conshohocken's newest hotels - Hotel West and Main!  We will be offering three legal education sessions offering CLE Credit.  Following our half-day program, we invite all attendees to join us for an outdoor networking happy hour to mingle with those in the HBP practice area.

1:30 p.m. - 2:00 p.m.
Registration

Session 1 - 2:00 p.m. - 3:00 p.m.
"Life Science Leasing – Not Your Parent’s Traditional Office Lease"
Presented by Cozen O'Connor

Life sciences industry growth is driving the demand for more lab and research space across the country. There has been an increase in new dedicated life sciences development and a surge in converting underperforming commercial and office real estate for use by life sciences companies. The panel will address the unique aspects of life sciences leasing compared to traditional office leases, focusing on commonly overlooked and unaddressed provisions in these leases. The discussion will also include a unique perspective of life sciences transactions from the C-Suite.

Speakers:

• Matthew Weinstein, Chair, Real Estate Lease Restructuring, Cozen O'Connor
• Adam Silverman, Member, Cozen O'Connor
• A.L. Braun, Vice President, Assistant General Counsel, Brandywine Realty Trust

Session 2 - 3:15 p.m. - 4:15 p.m.
"Recent Litigation Trends for the Pharmaceutical and Biotech Industry "
Presented by McCarter & English

The pharmaceutical and biotech industries are no stranger to litigation. This session will review recent litigation trends and significant cases impacting the industry and discuss what may be on the horizon. Topics will include Hatch-Waxman, BPCIA, 340B, and the impact of the Inflation Reduction Act.

Speakers:

• Daniel Silver, Partner, McCarter & English
• Sky Adams, Senior Litigation Counsel, AstraZeneca

Session 3 - 4:30 p.m. - 5:30 p.m.
"Managing Risk: An Analysis of Key Contract Provisions In Life Sciences Litigation" 
Presented by Shook Hardy & Bacon

When deals go bad or a collaboration goes wrong, it is often the "simple" boilerplate provisions and words that matter significantly in litigation: indemnity provisions, damages limitation provisions, force majeure and impracticability conditions, dispute resolution provisions, and "commercial reasonableness," to take a few examples.

Join Shook, Hardy & Bacon for this important webinar as we focus on the types of contract provisions that are most often at the center of disputes in the life sciences.

Tom Sullivan, a Litigation Partner at Shook, will analyze and discuss recent case law regarding these and other critical provisions to tease out the lessons learned from the disputes involving these provisions. Tom's extensive experience with complex commercial case in various industries, including health care and the life sciences, will help all in-house counsel become better business advisors for your companies.

Speakers:

• Stefon David, Associate, Shook Hardy & Bacon
• Thomas Sullivan, Partner, Shook Hardy & Bacon
• Don Mankoff, Vice President, Associate General Counsel, PTC Therapeutics, Inc.

5:30 p.m.  - 7:30 p.m.
Networking Cocktail Reception